Latest Articles

Publication Date
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer - AOL

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer AOL

Published: Jan. 21, 2025, 9:14 p.m.
GSK gets expanded EU approval for Jemperli in endometrial cancer - MSN

GSK gets expanded EU approval for Jemperli in endometrial cancer MSN

Published: Jan. 21, 2025, 7:31 p.m.
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer - Yahoo Finance

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer Yahoo Finance

Published: Jan. 21, 2025, 6:43 p.m.
GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer - Yahoo Finance

GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer Yahoo Finance

Published: Jan. 21, 2025, 2:35 p.m.
Painful Endometriosis Can Affect the Whole Body, Not Only the Pelvis - Scientific American

Painful Endometriosis Can Affect the Whole Body, Not Only the Pelvis Scientific American

Published: Jan. 21, 2025, 2:03 p.m.
EU approves endometrial, lung cancer drugs from GSK and J&J - pharmaphorum

EU approves endometrial, lung cancer drugs from GSK and J&J pharmaphorum

Published: Jan. 21, 2025, 1:59 p.m.
Bindi Irwin takes a big step after her crippling endometriosis diagnosis - News24

Bindi Irwin takes a big step after her crippling endometriosis diagnosis News24

Published: Jan. 21, 2025, 1:46 p.m.
GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer - TipRanks

GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer TipRanks

Published: Jan. 21, 2025, 12:20 p.m.
Endometriosis poses substantial burden on Australia’s health system - The Hippocratic Post

Endometriosis poses substantial burden on Australia’s health system The Hippocratic Post

Published: Jan. 21, 2025, 12:05 p.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - EIN News

Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR EIN News

Published: Jan. 21, 2025, 10:38 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!